Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of DEXTROMETHORPHAN (cas 125-71-3) in hearing loss rat model

Add time:09/24/2019    Source:sciencedirect.com

This study investigated the protective effects of DEXTROMETHORPHAN (cas 125-71-3) (DXM) on noise-induced hearing loss (NIHL) in rats. This study aimed to improve the auditory threshold and to understand the protective effects of DXM against N-methyl-d-aspartate (NMDA)-induced neurite degeneration of serotonergic neurons. The animals were exposed to 8-kHz narrowband noise at a 118-dB sound pressure level for 3.5 h. The hearing thresholds were determined by measuring the auditory brainstem response to click stimuli. Serotonin transporter (SERT) expression was determined through micro-positron emission tomography (PET) using N,N-dimethyl-2-(2-amino-4-18F-fluorophenylthio)benzylamine (4-[18F]-ADAM). We also investigated the effects of DXM on NMDA-induced morphological changes in the primary cultures of rat serotonergic neurons. NIHL significantly improved after prophylactic treatment with DXM (p < .05). SERT density in DXM-treated rats was significantly higher than that in non–DXM-treated rats. Because prophylactic medication restored the NMDA-inhibited neurite length of serotonergic neurons and presented SERT density, DXM could be a potential agent in alleviating NIHL.

We also recommend Trading Suppliers and Manufacturers of DEXTROMETHORPHAN (cas 125-71-3). Pls Click Website Link as below: cas 125-71-3 suppliers

Prev:Mutually augmenting interactions of DEXTROMETHORPHAN (cas 125-71-3) and sazetidine-A for reducing nicotine self-administration in rats
Next:Research reportThe blockade of 5-HT1A receptors in the ventral tegmental area inhibited morphine/DEXTROMETHORPHAN (cas 125-71-3)-induced analgesia in pain rat models)